Antithrombotic therapy for atrial fibrillation: CHEST guideline and expert panel report
Background The risk of stroke is heterogeneous across different groups of patients with atrial
fibrillation (AF), being dependent on the presence of various stroke risk factors. We provide …
fibrillation (AF), being dependent on the presence of various stroke risk factors. We provide …
GARFIELD-AF: a worldwide prospective registry of patients with atrial fibrillation at risk of stroke
JP Bassand, PN Apenteng, D Atar, AJ Camm… - Future …, 2021 - Taylor & Francis
The Global Anticoagulant Registry in the Field-Atrial Fibrillation (GARFIELD-AF) examined
real-world practice in a total of 57,149 (5069 retrospective, 52,080 prospective) patients with …
real-world practice in a total of 57,149 (5069 retrospective, 52,080 prospective) patients with …
Quality of vitamin K antagonist control and 1-year outcomes in patients with atrial fibrillation: a global perspective from the GARFIELD-AF registry
S Haas, H Ten Cate, G Accetta, P Angchaisuksiri… - PloS one, 2016 - journals.plos.org
Aims Vitamin K antagonists (VKAs) need to be individually dosed. International guidelines
recommend a target range of international normalised ratio (INR) of 2.0–3.0 for stroke …
recommend a target range of international normalised ratio (INR) of 2.0–3.0 for stroke …
[HTML][HTML] Antithrombotic treatment in patients with hemophilia: an EHA-ISTH-EAHAD-ESO clinical practice guidance
REG Schutgens, V Jimenez-Yuste, M Escobar… - …, 2023 - journals.lww.com
Cardiovascular disease is an emerging medical issue in patients with hemophilia (PWH)
and its prevalence is increasing up to 15% in PWH in the United States. Atrial fibrillation …
and its prevalence is increasing up to 15% in PWH in the United States. Atrial fibrillation …
[HTML][HTML] Neuropathological implication of high blood bilirubin in patients and model rats with depression
Y Gao, Y Ling, J Li, Y Xu, J Ge, Q Xia - Brain Research Bulletin, 2024 - Elsevier
Purpose Elevated bilirubin levels have been associated with major depressive disorder
(MDD); however, the exact impact of bilirubin on MDD and the underlying molecular …
(MDD); however, the exact impact of bilirubin on MDD and the underlying molecular …
[HTML][HTML] 氧化石墨烯的表面处理及其在生物医学领域的应用
张园园， 杨宁文， 何星 - 2022 - snm.usst.edu.cn
氧化石墨烯(graphene oxide, GO) 表面具有丰富的含氧基团. 通过共价键结合, 疏水作用,
氢键作用等吸附药物和其他大分子对GO 表面微观结构的修饰可提升其实用性 …
氢键作用等吸附药物和其他大分子对GO 表面微观结构的修饰可提升其实用性 …
A pharmacogenetically guided acenocoumarol dosing algorithm for Chilean patients: A discovery cohort study
A Roco, E Nieto, M Suárez, M Rojo… - Frontiers in …, 2020 - frontiersin.org
Background Vitamin K antagonists (VKA) are used as prophylaxis for thromboembolic
events in patients with cardiovascular diseases. The most common VKA are warfarin and …
events in patients with cardiovascular diseases. The most common VKA are warfarin and …
Diagnostic accuracy of a novel chromogenic direct thrombin inhibitor assay: clinical experiences for dabigatran monitoring
Background Direct oral anticoagulants (DOACs) are increasingly replacing vitamin K
antagonists (VKA) for clinical indications requiring long-term oral anticoagulation. In contrast …
antagonists (VKA) for clinical indications requiring long-term oral anticoagulation. In contrast …
Predictive ability of visit-to-visit blood pressure indices for adverse events in patients with non-valvular atrial fibrillation: Subanalysis of the J-RHYTHM Registry
E Kodani, H Inoue, H Atarashi, K Okumura… - IJC Heart & …, 2023 - Elsevier
Background We previously reported that standard deviation (SD) of systolic blood pressure
(SBP), an index of BP variability, and SBP-time in target range (TTR), an index of BP …
(SBP), an index of BP variability, and SBP-time in target range (TTR), an index of BP …
Use of antithrombotic therapy in patients with hemophilia: a selected synopsis of the European Hematology Association-International Society on Thrombosis and …
M Escobar, R Lassila, C Bekdache… - Journal of Thrombosis …, 2024 - jthjournal.org
Here, we summarize the European Hematology Association-International Society on
Thrombosis and Haemostasis-European Association for Hemophilia and Allied Disorders …
Thrombosis and Haemostasis-European Association for Hemophilia and Allied Disorders …